According to a group of U.S. researchers, a drug created from both a fungus that contaminated a lab experiment, and nanotechnology could be effective in fighting a broad range of cancers. The drug, called lodamin was improved in one of the final experiments overseen by recently deceased Dr. Judah Folkman, a pioneer of angiogenesis therapy – ...